SERINA THERAPEUTICS INC. (SER) Stock Earnings & Estimates
NYSEARCA:SER - US81751A1088 - Common Stock
5.09 USD
-0.19 (-3.6%)
5 USD
-0.09 (-1.77%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30K -78.57% | 142K 373.33% | 56K -60.56% | -100.00% | |||
| EBITDA YoY % growth | -6.85M 13.40% | -9.829M -43.49% | -16.854M -71.47% | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.98M 13.18% | -9.96M -42.69% | -17.048M -71.16% | -24.06M -41.13% | -30.739M -27.76% | -34.128M -11.02% | |
| Operating Margin | -23,266.67% | -7,014.08% | -30,442.86% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.74 | -1.68 3.48% | -1.29 23.12% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 16.52% | -0.42 36.49% | -0.42 6.67% | -0.43 -60.85% |
| Revenue Q2Q % growth | -100.00% | 100.00% | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.537M -28.66% | -7.766M -39.55% | -7.88M -35.26% | -7.996M -25.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.27 | -0.42 | 0.15 | 36.35% |
| Q2 2025 Q2Q % growth | -0.66 | -0.43 | -0.23 | -53.76% |
| Q1 2025 Q2Q % growth | -0.49 | -0.63 | 0.14 | 21.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -100.00% | % | ||
| Q2 2025 Q2Q % growth | 130K 154.90% | 130K | % | |
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | 14K -80.00% | % | ||
| Q2 2024 Q2Q % growth | 51K 410.00% | % | ||
| Q1 2024 Q2Q % growth | 5K -50.00% | % | ||
| Q4 2023 Q2Q % growth | 56K 460.00% | % | ||
| Q3 2023 Q2Q % growth | 70K 600.00% | % | ||
| Q2 2023 Q2Q % growth | 10K | % | ||
| Q1 2023 Q2Q % growth | 10K | % | ||
| Q4 2022 Q2Q % growth | 10K -66.67% | % | ||
| Q3 2022 Q2Q % growth | 10K -50.00% | % | ||
| Q2 2022 Q2Q % growth | 10K -75.00% | % | ||
| Q1 2022 Q2Q % growth | 10K -83.33% | % | ||
| Q4 2021 Q2Q % growth | 30K -81.25% | % | ||
| Q3 2021 Q2Q % growth | 20K -71.43% | % | ||
| Q2 2021 Q2Q % growth | 40K -20.00% | % | ||
| Q1 2021 Q2Q % growth | 60K -33.33% | % | ||
| Q4 2020 Q2Q % growth | 160K -70.91% | % | ||
| Q3 2020 Q2Q % growth | 70K -82.93% | % | ||
| Q2 2020 Q2Q % growth | 50K -86.84% | % | ||
| Q1 2020 Q2Q % growth | 90K -76.92% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.43% | N/A | 11.54% | 11.54% |
| Revenue | N/A | N/A | N/A | N/A |